Truvada
![Gilead Sciences Proceeds with $247 Million Settlement in HIV Antitrust Case Following Trial Victory](https://pharmtales.com/wp-content/uploads/2023/09/Gilead-settles-with-direct-purchasers-of-HIV-drugs-Truvada-and-Atripla-for-247M.jpg)
Gilead Sciences Proceeds with $247 Million Settlement in HIV Antitrust Case Following Trial Victory
Anika Sharma
Despite Gilead Sciences and Teva Pharmaceutical Industries emerging victorious in a high-stakes antitrust trial related to HIV drugs earlier this ...
![Gilead and Teva were acquitted in a $3.6 billion trial involving alleged 'pay-for-delay' schemes - Pharmtales](https://pharmtales.com/wp-content/uploads/2023/07/Gilead-and-Teva-were-acquitted-in-a-3.6-billion-trial-involving-alleged-pay-for-delay-schemes.jpg)
Gilead and Teva were acquitted in a $3.6 billion trial involving alleged ‘pay-for-delay’ schemes
SG Tylor
Gilead Sciences and Teva have been exonerated by a California court jury in a lawsuit accusing them of colluding to ...